U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07224477) titled 'A Clinical Study of V540A in Healthy Female Participants (V540A-005)' on Nov. 03.
Brief Summary: Researchers are looking for new ways to prevent cancers related to human papillomavirus (HPV). HPV is a common virus that can cause an infection. There are many different types of HPV.
A standard vaccine to prevent HPV-related cancers is V503. V503 protects against 9 types of HPV. V540A is a study vaccine designed to protect against the same (shared) 9 HPV types plus other (unique) HPV types.
Researchers want to learn if V540A:
* Is safe and if people tolerate it
* Works as well as V503 to cause an immune response (the body's response...